Leica Biosystems announces partnership with Indica Labs to deliver integrated digital pathology workflow solutions for mutual customers
The collaboration is focused on delivering compatible digital pathology workflow solutions
25 Oct 2022
Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, an industry-leading provider of computational and image management software in digital pathology, have announced a partnership focused on delivering compatible digital pathology workflow solutions.
The agreement establishes a cooperation between Leica Biosystems and Indica Labs with a commitment to maintain ongoing file format compatibility between Leica Biosystems Aperio GT 450 family of scanners with Indica Labs Halo family of software solutions, including AI-enabled image analysis and image management workflow software.
“The Indica team is delighted to formalize our relationship with Leica Biosystems. The partnership solidifies our commitment to ensuring that Leica Biosystems state-of-the art slide scanners, reagents, and instrumentation can be coupled with our leading digital workflow and analytics software,” said Steven Hashagen, CEO of Indica Labs. “Customers can rest assured that both companies are working proactively to meet the regulatory and technical integration needs of the industry.”
“For customers using Leica Biosystems Aperio GT 450 family platforms who are seeking AI-enabled image analysis and image management applications, this new partnership can eliminate integration challenges and provides our customers with peace of mind when implementing a digital pathology workflow with Indica’s HALO product portfolio,“ said Gustavo Perez, President of Leica Biosystems.
